全国范围的分析变量与 Sarcoid 入院患者死亡率相关的变量
Michael Manansala1, Janelle Castellino1, Shilpa Arora
1From the Rush University Medical Center.
概括
Sarcoidosis患者面临2.5%的住院死亡率. 型硬化症死亡率的关键风险因素包括晚年,并发病,男性性别以及肝硬化和感染等特定疾病.
科学领域:
- 内部医学 内部医学
- 肺部病理学 肺部病理学
- 心脏病学 心脏病学
- 神经学 神经学
- 肝病学 肝病学是一种肝病学.
背景情况:
- Sarcoidosis 是一种复杂的多系统自身免疫性疾病.
- 它可以导致大量的患者发病率和死亡率.
- 确定医院死亡的预测因素对于改善患者的治疗结果至关重要.
研究的目的:
- 为了确定与类病患者在医院死亡率相关的因素.
- 分析国家一级的数据,以全面了解 Sarcoidosis 的结果.
- 为高风险的类病患者提供临床意识和管理策略的信息.
主要方法:
- 进行了回顾性医疗记录审查.
- 数据是从国家住院样本数据库 (2016-2020) 中提取的.
- 单变量和多变量分析确定了医院死亡的预测因素.
主要成果:
- 分析了超过40万5千例肉病入院病例,10210例死亡 (2.5%的死亡率).
- 住院死亡的独立预测因素包括:年龄,查尔森并发症指数,男性性别,其他种族,心律不整/心脏阻塞,肝硬化/肝衰竭,血细胞淋巴细胞结核,感染,间歇性肺病,心力衰竭/心肌炎,神经学诊断和肺高血压.
- 具体的疾病,如肝硬化/肝衰竭和血细胞性淋巴细胞细胞瘤,显示死亡率明显增加.
结论:
- 这项研究确定了与类病患者在医院死亡相关的关键因素.
- 意识到这些风险因素 (例如年龄,并发症,特定器官参与) 可以提高临床警.
- 对这些危及生命的并发症的早期识别和干预可能会改善沙尔科病的住院患者的治疗结果.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
221
10:46A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
10.7K
相关概念视频
01:21Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
01:20Actuarial Approach
63
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
63
01:20Comparing the Survival Analysis of Two or More Groups
154
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
154
01:15Assumptions of Survival Analysis
97
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
97
01:25Statistical Methods for Analyzing Epidemiological Data
308
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
308
01:24Kaplan-Meier Approach
100
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
100